SMS Pharmaceuticals Limited has informed the Exchange about General Updates

Regulatory & Legal View source PDF Explain this filing

SMSPHARMA · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+0.6%Reaction day

₹247.50

prior close

₹249.40

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+0.5%+0.1% vs market

Pharmaceuticals peers, median of 150sector+0.6%+0.0% vs sector

On the reaction day the stock moved 0.1 pts more than Nifty Microcap 250 and in line with its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.5

10m

+0.3

15m

+0.5

30m

+0.6

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+0.6+0.5+0.1+0.6+0.0

Next day

+1.6+1.4+0.2+1.4+0.2

-0.6+1.5-2.1+1.4-2.0

-3.8+1.3-5.1+1.1-4.9

-1.9+1.3-3.2+1.3-3.2

-1.5+1.8-3.2+1.7-3.2

-3.0+1.2-4.2+0.8-3.8

15d

+2.0+3.1-1.1+3.8-1.8

-3.0-0.8-2.2+1.3-4.3

-10.1-3.5-6.6-3.7-6.4

-0.8-3.7+3.0-3.6+2.8

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 150Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

SMS Pharmaceuticals has informed exchanges that an operational creditor, M/s. Sai Sreyas Pharmaceutical Private Limited, has filed a petition under Section 9 of the Insolvency and Bankruptcy Code (IBC) before the NCLT Hyderabad Bench. The petition alleges a default of ₹3.02 Crores in unpaid operational debt and seeks initiation of Corporate Insolvency Resolution Process (CIRP) against the company. The NCLT has registered the matter on 25.06.2025. The company disputes the claim, citing quality issues with materials supplied by the petitioner and had previously asked them to take back the disputed material. The company is seeking legal advice and intends to contest the petition to protect its interests.

Likely market impact

This is a negative development for shareholders as it raises the prospect of insolvency proceedings against the company. However, the petition is only at the registration stage and has not been admitted yet, and the company is actively contesting it. Investors should monitor further updates on the NCLT proceedings as admission of the petition could lead to significant disruption.